| Features: |
| Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes. Radiosensitizer Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer. |
| Source: |
| Type: |
| ALDOA (Aldolase A) is an enzyme involved in glycolysis, the metabolic pathway that converts glucose into energy. Expression level of ALDOA was significantly related to the prognosis of brain cancer, skin cancer, lung adenocarcinoma and breast cancer. Aldolase enzymes, particularly ALDOA, ALDOB, and ALDOC, play a crucial role in the development and progression of cancer. While the aldolase family is mainly known for its involvement in the glycolysis pathway, these enzymes also have various pathological and physiological functions through distinct signaling pathways such as Wnt/β-catenin, EGFR/MAPK, Akt, and HIF-1α. ALDOA (Aldolase A) is an enzyme involved in glycolysis, the metabolic pathway that converts glucose into energy. ALDOA is often overrepresented and has been associated with poor prognosis in various malignancies. Its expression levels can serve as potential biomarkers for tumor aggressiveness and patient outcomes. |
| 2289- | Ba, | Rad, | Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A |
| - | in-vitro, | ESCC, | KYSE150 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:201 Target#:567 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid